Fiscal Year:
2008
Title:
Programmable Transdermal Drug Delivery
Agency:
HHS
Contract:
1R43AR055837-01
Award Amount:
$99,996.00
Abstract:
DESCRIPTION (provided by applicant): Prostate cancer and central precocious puberty linked through improper gonadal steroid levels - are most common in either the elderly or youth populations. Similar gonadal steroid problems also connected to endometrios
is. Some traditional methodologies for treating these illnesses involves daily injections of medicine, which can become painful or be forgotten, result in under-dosing. Los Gatos Research is developing an alternative method for delivering time-controlled d
rug formulations that is practically pain free. Furthermore, the novel technology provides an extended, programmable release platform that helps patients avoid the need to remember to take medication (particularly important for portions of the elderly popu
lation) and offers the potential to use less medicine to produce the same effect due to the ability to customize the delivery to the individual patient. The technologies developed in this proposed project enable programmable, microfluidic transdermal patch
es to provide a means for delivering large molecular weight drug formulations that is controlled, painless, and direct. The specific aims of the Phase I project include fabricating the unique programmable transdermal patches, testing and validating their p
erformance capabilities, and optimizing them for rapid, controlled delivery of medication to control gonadal steroid levels.
Principal Investigator:
Business Contact:
Small Business Information at Submission:
LOS GATOS RESEARCH
LOS GATOS RESEARCH 67 E EVELYN AVE, STE 3 MOUNTAIN VIEW, CA 94041
EIN/Tax ID:
770358688
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned:
No
Minority-Owned:
No
HUBZone-Owned:
No